CELA3B

gene
On this page

Also known as CBPP

Summary

CELA3B (chymotrypsin like elastase 3B, HGNC:15945) is a protein-coding gene on chromosome 1p36.12, encoding Chymotrypsin-like elastase family member 3B (P08861). Efficient protease with alanine specificity but only little elastolytic activity.

Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode the structurally similar proteins elastase 1, 2, 2A, 2B, 3A, and 3B. Unlike other elastases, elastase 3B has little elastolytic activity. Like most of the human elastases, elastase 3B is secreted from the pancreas as a zymogen and, like other serine proteases such as trypsin, chymotrypsin and kallikrein, it has a digestive function in the intestine. Elastase 3B preferentially cleaves proteins after alanine residues. Elastase 3B may also function in the intestinal transport and metabolism of cholesterol. Both elastase 3A and elastase 3B have been referred to as protease E and as elastase 1, and excretion of this protein in fecal material is frequently used as a measure of pancreatic function in clinical assays.

Source: NCBI Gene 23436 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 63 total
  • MANE Select transcript: NM_007352

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:15945
Approved symbolCELA3B
Namechymotrypsin like elastase 3B
Location1p36.12
Locus typegene with protein product
StatusApproved
AliasesCBPP
Ensembl geneENSG00000219073
Ensembl biotypeprotein_coding
OMIM618694
Entrez23436

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 2 protein_coding, 2 protein_coding_CDS_not_defined

ENST00000337107, ENST00000374666, ENST00000400277, ENST00000473526

RefSeq mRNA: 1 — MANE Select: NM_007352 NM_007352

CCDS: CCDS219

Canonical transcript exons

ENST00000337107 — 8 exons

ExonStartEnd
ENSE000009564262198103821981172
ENSE000009564292198418921984331
ENSE000014642112197702221977082
ENSE000016131422198369421983830
ENSE000017249872198082421980921
ENSE000017617322197836921978454
ENSE000018900982198926221989354
ENSE000036595032198653121986683

Expression profiles

Bgee: expression breadth ubiquitous, 125 present calls, max score 99.93.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 30.5644 / max 52552.5631, expressed in 14 samples.

FANTOM5 promoters (15 alternative TSS)

Promoter IDTPM avgSamples expressed
124430.564414
12430.31493
12450.31074
12480.17024
12420.09033
12490.08904
12460.06603
12510.05633
12410.04443
12520.04212

Top tissues by expression

133 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
body of pancreasUBERON:000115099.93gold quality
pancreasUBERON:000126497.29gold quality
islet of LangerhansUBERON:000000691.96gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.69silver quality
body of stomachUBERON:000116178.57gold quality
fundus of stomachUBERON:000116077.60gold quality
duodenumUBERON:000211475.58gold quality
ectocervixUBERON:001224973.84gold quality
stomachUBERON:000094573.78gold quality
right coronary arteryUBERON:000162573.32gold quality
right lobe of liverUBERON:000111471.17gold quality
placentaUBERON:000198770.98gold quality
left uterine tubeUBERON:000130370.75gold quality
endocervixUBERON:000045870.09gold quality
descending thoracic aortaUBERON:000234569.83gold quality
right adrenal glandUBERON:000123368.57gold quality
right uterine tubeUBERON:000130267.95gold quality
uterine cervixUBERON:000000267.83gold quality
lower esophagus mucosaUBERON:003583467.52gold quality
right adrenal gland cortexUBERON:003582767.39gold quality
left adrenal gland cortexUBERON:003582567.27gold quality
thoracic aortaUBERON:000151566.99gold quality
left adrenal glandUBERON:000123466.89gold quality
ascending aortaUBERON:000149666.85gold quality
transverse colonUBERON:000115766.66gold quality
apex of heartUBERON:000209865.98gold quality
lower esophagusUBERON:001347365.38gold quality
lower esophagus muscularis layerUBERON:003583365.26gold quality
body of uterusUBERON:000985365.09gold quality
metanephros cortexUBERON:001053364.91gold quality

Single-cell (SCXA)

Detected in 7 experiment(s), a significant marker in 4.

ExperimentMarker?Max mean expression
E-ENAD-27yes10856.99
E-GEOD-81547yes31.34
E-MTAB-5061yes18.91
E-GEOD-111727no44.33
E-HCAD-31no3.26
E-GEOD-83139no3.11
E-ANND-3no0.00

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 20)

  • As an independent variable, correlated with C-peptide and HBA1c levels in type 1 diabetes. (PMID:15277440)
  • pancreatic elastase induced proinflammatory effects are mediated by TLR4 and NF-kappaB in human myeloid cells (PMID:15351720)
  • Patients with type 1 diabetes and low fecal elastase 1 concentrations were succesfully treatted with pancretin. (PMID:17103488)
  • Fecal fat excretion is increased in patients with type 2 diabetes with fecal elastase deficiency. (PMID:17989309)
  • Neither low fecal elastase 1 nor raised fecal fat levels reliably indicate exocrine pancreatic insufficiency in type-1 diabetes. (PMID:18362841)
  • Reduced fecal elastase 1 connected with lowered serum levels of vitamin D3 is associated with osteoporotic bone fractures. (PMID:18424365)
  • Parathormone levels and Vitamin D metabolism in female patients with various grades of fecal ELA1 deficiency are reported. (PMID:19073396)
  • Hypermethylation of ELA3B gene promoter were associated with pancreatic cancer. (PMID:20428826)
  • FE-1 is a poor surrogate for diagnosing impaired fat absorption. (PMID:22094930)
  • A low value of faecal elastase-1, indicating reduced exocrine pancrease secretion, is strongly correlated with a poor survival in advanced pancreatic cancer. (PMID:22749648)
  • Recombinant type I pancreatic elastase improves unassisted arteriovenous fistula maturation in hemodialysis patients. (PMID:24684771)
  • The results of the study suggest that the levels of apelin, TNF-alpha and elastase-1 are important diagnostic markers of CP in patients with type 2 diabetes mellitus. (PMID:26817104)
  • this study demonstrated a strong association of diabetes with low pancreatic elastase levels in feces (PMID:27069032)
  • Complex Formation of Human Proelastases with Procarboxypeptidases A1 and A2. (PMID:27358403)
  • variants affecting amino-acid position 241 in CELA3A and CELA3B are not associated with chronic pancreatitis, indicating that changes in complex formation between proelastases and procarboxypeptidases do not alter pancreatitis risk. (PMID:27999401)
  • The aim of this study was to examine the frequency of exocrine dysfunctions of the pancreas according to the level of fecal elastase-1 (FE-1) in patients with diabetes mellitus, type 1 and diabetes mellitus, type 2. (PMID:30106003)
  • Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma. (PMID:31369399)
  • The reversion variant (p.Arg90Leu) at the evolutionarily adaptive p.Arg90 site in CELA3B predisposes to chronic pancreatitis. (PMID:33565216)
  • Utility of Fecal Elastase-1 to diagnose severe exocrine insufficiency in chronic pancreatitis: Real world experience. (PMID:36610873)
  • Does the Complex of CELA3B Variants With Other Pancreatitis-Related Genes Affect Developing Childhood Pancreatitis? (PMID:37307306)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
mus_musculusCela3bENSMUSG00000023433
mus_musculusCela3aENSMUSG00000078520
rattus_norvegicusCela3bENSRNOG00000021619

Paralogs (6): CELA1 (ENSG00000139610), CELA2A (ENSG00000142615), CELA3A (ENSG00000142789), PRTN3 (ENSG00000196415), ELANE (ENSG00000197561), CELA2B (ENSG00000215704)

Protein

Protein identifiers

Chymotrypsin-like elastase family member 3BP08861 (reviewed: P08861)

Alternative names: Elastase IIIB, Elastase-3B, Protease E

All UniProt accessions (2): P08861, A0A0A0MSA6

UniProt curated annotations — full annotation on UniProt →

Function. Efficient protease with alanine specificity but only little elastolytic activity.

Tissue specificity. Pancreas. Not detectable in keratinocytes.

Similarity. Belongs to the peptidase S1 family. Elastase subfamily.

RefSeq proteins (1): NP_031378* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001254Trypsin_domDomain
IPR001314Peptidase_S1AFamily
IPR009003Peptidase_S1_PAHomologous_superfamily
IPR018114TRYPSIN_HISActive_site
IPR033116TRYPSIN_SERActive_site
IPR043504
IPR050850Peptidase_S1_Elastase_sfFamily

Pfam: PF00089

UniProt features (18 total): disulfide bond 5, sequence conflict 4, active site 3, signal peptide 1, propeptide 1, sequence variant 1, chain 1, domain 1, glycosylation site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P08861-F191.130.85

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (3): 73 (charge relay system); 123 (charge relay system); 217 (charge relay system)

Disulfide bonds (5): 157–223, 188–204, 213–244, 58–74, 117–120

Glycosylation sites (1): 114

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-9925561Developmental Lineage of Pancreatic Acinar Cells
R-HSA-1266738Developmental Biology
R-HSA-9734767Developmental Cell Lineages

MSigDB gene sets: 53 (showing top): YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN, MYOD_01, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5, GATA1_04, TAL1BETAE47_01, SANSOM_APC_TARGETS, GOBP_PROTEOLYSIS, E2A_Q2, GOMF_PEPTIDASE_ACTIVITY, chr1p36, BIOCARTA_PEPI_PATHWAY, SERVITJA_LIVER_HNF1A_TARGETS_UP, GATA1_05, FOXN3_TARGET_GENES, ZNF436_TARGET_GENES

GO Biological Process (1): proteolysis (GO:0006508)

GO Molecular Function (4): serine-type endopeptidase activity (GO:0004252), peptidase activity (GO:0008233), serine-type peptidase activity (GO:0008236), hydrolase activity (GO:0016787)

GO Cellular Component (1): obsolete extracellular space (GO:0005615)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Developmental Cell Lineages of the Exocrine Pancreas1
Developmental Biology1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein metabolic process1
endopeptidase activity1
serine-type peptidase activity1
hydrolase activity1
catalytic activity, acting on a protein1
peptidase activity1
serine hydrolase activity1
catalytic activity1

Protein interactions and networks

STRING

826 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CELA3BSCTP09683644
CELA3BCPA1P15085627
CELA3BSPINK1P00995546
CELA3BCPA2P48052542
CELA3BPNLIPP16233542
CELA3BPNLIPRP1P54315507
CELA3BCPB1P15086501
CELA3BENPEPQ07075480
CELA3BCFTRP13569477
CELA3BSYCNQ0VAF6468
CELA3BINSP01308421
CELA3BPTF1AQ7RTS3399
CELA3BCELP19835393
CELA3BGRNP23781385
CELA3BGCGP01275385

IntAct

3 interactions, top by confidence:

ABTypeScore
CELA3BBCAT2psi-mi:“MI:0914”(association)0.350
CELA3BHBDpsi-mi:“MI:0914”(association)0.350

BioGRID (14): CELA3B (PCA), TIMP3 (Affinity Capture-MS), NME2 (Affinity Capture-MS), GRN (Affinity Capture-MS), UBR7 (Affinity Capture-MS), SERPINB1 (Affinity Capture-MS), BCAT2 (Affinity Capture-MS), ADAMTS1 (Affinity Capture-MS), CELA3A (Affinity Capture-MS), UBR2 (Affinity Capture-MS), GDF15 (Affinity Capture-MS), HSP90AA4P (Affinity Capture-MS), HBD (Affinity Capture-MS), CELA3B (Positive Genetic)

ESM2 similar proteins: A0A126GUP6, A0A1S4H5M5, A0A6J1W8N1, B5U2W0, F5HKX0, O19023, O46644, O97366, P00772, P00773, P00774, P05208, P05805, P06871, P06872, P07477, P07478, P08217, P08218, P08419, P08861, P09093, P13582, P16049, P21902, P47796, P55091, P80009, P80010, Q29461, Q2VG86, Q3SYP2, Q49QW1, Q5R1M5, Q7M3E1, Q7M4I3, Q7PEV7, Q7QBP4, Q867B0, Q8I6K0

Diamond homologs: A1KXI1, C0HKF7, C0HKF8, O19023, O60235, O97370, O97398, P00760, P00761, P00762, P00763, P00764, P00765, P00766, P00767, P00768, P00769, P00771, P00774, P03951, P03952, P04813, P04814, P05208, P05805, P06871, P06872, P07146, P07338, P07477, P07478, P08217, P08218, P08419, P08426, P08861, P08897, P09093, P12788, P15947

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

63 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance48
Likely benign8
Benign4

Top pathogenic / likely-pathogenic (0)

SpliceAI

1010 predictions. Top by Δscore:

VariantEffectΔscore
1:21978367:A:AGacceptor_gain1.0000
1:21978368:G:GAacceptor_gain1.0000
1:21978368:GCCT:Gacceptor_gain1.0000
1:21980814:G:Aacceptor_gain1.0000
1:21980922:G:GGdonor_gain1.0000
1:21981033:CGCA:Cacceptor_loss1.0000
1:21981035:CAG:Cacceptor_loss1.0000
1:21981036:A:AGacceptor_gain1.0000
1:21981036:A:Gacceptor_loss1.0000
1:21981036:AG:Aacceptor_gain1.0000
1:21981037:G:GTacceptor_gain1.0000
1:21981037:GG:Gacceptor_gain1.0000
1:21981037:GGA:Gacceptor_gain1.0000
1:21981037:GGAGC:Gacceptor_gain1.0000
1:21981169:GTGG:Gdonor_gain1.0000
1:21981171:GG:Gdonor_gain1.0000
1:21981172:GG:Gdonor_gain1.0000
1:21981172:GGTG:Gdonor_loss1.0000
1:21981173:G:Cdonor_loss1.0000
1:21981173:G:GGdonor_gain1.0000
1:21981174:TGA:Tdonor_loss1.0000
1:21981175:GAGT:Gdonor_loss1.0000
1:21981176:AGTG:Adonor_loss1.0000
1:21981177:G:Cdonor_loss1.0000
1:21983831:G:GGdonor_gain1.0000
1:21984184:T:Aacceptor_gain1.0000
1:21984184:TGCA:Tacceptor_loss1.0000
1:21984186:CA:Cacceptor_loss1.0000
1:21984187:A:AGacceptor_gain1.0000
1:21984188:G:GAacceptor_gain1.0000

AlphaMissense

1747 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:21983817:G:CW162C1.000
1:21983817:G:TW162C1.000
1:21983699:A:CD123A0.999
1:21983699:A:TD123V0.999
1:21984299:T:AC204S0.999
1:21984300:G:CC204S0.999
1:21984326:T:AC213S0.999
1:21984327:G:CC213S0.999
1:21986535:A:TD216V0.999
1:21980867:G:AC58Y0.998
1:21980915:G:AC74Y0.998
1:21980916:C:GC74W0.998
1:21983698:G:CD123H0.998
1:21983699:A:GD123G0.998
1:21983802:C:GC157W0.998
1:21983815:T:AW162R0.998
1:21983815:T:CW162R0.998
1:21983818:G:TG163C0.998
1:21984251:T:AC188S0.998
1:21984252:G:CC188S0.998
1:21984327:G:AC213Y0.998
1:21986535:A:CD216A0.998
1:21986541:G:TG218V0.998
1:21986597:A:CS237R0.998
1:21986599:C:AS237R0.998
1:21986599:C:GS237R0.998
1:21986618:T:AC244S0.998
1:21986619:G:CC244S0.998
1:21986645:T:CF253L0.998
1:21986647:C:AF253L0.998

dbSNP variants (sampled 300 via entrez): RS1000509788 (1:21977652 C>T), RS1000637248 (1:21982931 T>C), RS1000898902 (1:21996096 C>A), RS1000950544 (1:21995790 G>A), RS1001079154 (1:21987513 G>T), RS1001353295 (1:21981340 G>A,T), RS1001533503 (1:21987193 G>A), RS1001568076 (1:21992847 C>T), RS1001620607 (1:21992660 G>A), RS1001855907 (1:21975813 T>G), RS1002205922 (1:21985125 T>A,G), RS1002307005 (1:21981950 C>A,T), RS1002472601 (1:21998981 G>A), RS1002685986 (1:21996599 C>T), RS1002892608 (1:21975301 A>G)

Disease associations

OMIM: gene MIM:618694 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST90002394_127Monocyte percentage of white cells5.000000e-18
GCST90002407_388White blood cell count1.000000e-12

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007989monocyte percentage of leukocytes

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

2 total (human), top 2 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneincreases expression, increases methylation2
Aflatoxin B1increases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.